CD4 and neoplasm: Immunohistochemical staining of tumor tissues showed that DTT-COS12 treatments had a more positive area with anti-CD8 than control (Supplementary Figure S1A,B), and in contrast less positive area with anti-CD4 (Supplementary Figure S1A,C).